iowh032
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT01823939)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- iowh032
- iowh032
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04150250 | Phase 2 | Nov 30, 2019 | PATH, Pharmaron, University of Maryland |
| NCT02111304 | Phase 2 | Jun 1, 2014 | Bill and Melinda Gates Foundation, International Center for Diarrheal Disease Research, PATH |
| NCT01823939 | Phase 1 | May 1, 2013 | International Center for Diarrheal Disease Research, PATH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PATH | Academic/Hospital | 3 | 3 | 2 | 2013 |
| International Center for Diarrheal Disease Research | Academic/Hospital | 2 | 0 | 2 | 2013 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Pharmaron | For profit | 1 | 0 | 1 | 2019 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1